Analystreport

Oyster Point Pharma, Inc. (NASDAQ: OYST) was downgraded by analysts at Piper Sandler from an "overweight" rating to a "neutral" rating.

Oyster Point Pharma, Inc. - common stock  (OYST) 
Last oyster point pharma, inc. - common stock earnings: 2/27 04:01 pm Check Earnings Report